Central European Journal of Biology

, Volume 1, Issue 1, pp 29–42

Search for proteins with similarity to the CFTR R domain using an optimized RDBMS solution, mBioSQL

Research Article


The cystic fibrosis transmembrane conductance regulator (CFTR) comprises ATP binding and transmembrane domains, and a unique regulatory (R) domain not found in other ATP binding cassette proteins. Phosphorylation of the R domain at different sites by PKA and PKC is obligatory for the chloride channel function of CFTR. Sequence similarity searches on the R domain were uninformative. Furthermore, R domains from different species show low sequence similarity. Since these R domains resemble each other only in the location of the phosphorylation sites, we generated different R domain patterns masking amino acids between these sites. Because of the high number of the generated patterns we expected a large number of matches from the UniProt database. Therefore, a relational database management system (RDBMS) was set up to handle the results. During the software development our system grew into a general package which we term Modular BioSQL (mBioSQL). It has higher performance than other solutions and presents a generalized method for the storage of biological result-sets in RDBMS allowing convenient further analysis. Application of this approach revealed that the R domain phosphorylation pattern is most similar to those in nuclear proteins, including transcription and splicing factors.


Cystic fibrosis CFTR regulatory domain phosphorylation relational database management system 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    J.R. Riordan et al.: “Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA”, Science, Vol. 245, (1989), pp. 1066–1073.PubMedGoogle Scholar
  2. [2]
    Y.H. Ko and P.L. Pedersen: “Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease”, J. Bioenerg. Biomembr., Vol. 33, (2001), pp. 513–521.PubMedCrossRefGoogle Scholar
  3. [3]
    S.H. Cheng et al.: “Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel”, Cell, Vol. 66, (1991), pp. 1027–1036.PubMedCrossRefGoogle Scholar
  4. [4]
    F.S. Seibert et al.: “Influence of phosphorylation by protein kinase A on CFTR at the cell surface and endoplasmic reticulum”, Biochim. Biophys. Acta, Vol. 1461, (1999), pp. 275–283.PubMedCrossRefGoogle Scholar
  5. [5]
    L. Csanady et al.: “Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA”, J. Gen. Physiol., Vol. 125, (2005), pp. 171–186.PubMedCrossRefGoogle Scholar
  6. [6]
    D.C. Gadsby and A.C. Nairn: “Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis”, Physiol. Rev., Vol. 79, (1999), pp. S77–S107.PubMedGoogle Scholar
  7. [7]
    C. Li et al.: “ATPase activity of the cystic fibrosis transmembrane conductance regulator”, J. Biol. Chem., Vol. 271, (1996), pp. 28463–28468.PubMedCrossRefGoogle Scholar
  8. [8]
    J.R. Riordan: “Assembly of functional CFTR chloride channels”, Annu. Rev. Physiol., Vol. 67, (2005), pp. 701–718.PubMedCrossRefGoogle Scholar
  9. [9]
    D.P. Rich et al.: “Regulation of the cystic fibrosis transmembrane conductance regulator Cl-channel by negative charge in the R domain”, J. Biol. Chem., Vol. 268, (1993), pp. 20259–20267.PubMedGoogle Scholar
  10. [10]
    V. Chappe et al.: “Phosphorylation of CFTR by PKA promotes binding of the regulatory domain”, Embo. J., Vol. 24, (2005), pp. 2730–2740.PubMedCrossRefGoogle Scholar
  11. [11]
    A.M. Dulhanty and J.R. Riordan: “A two-domain model for the R domain of the cystic fibrosis transmembrane conductance regulator based on sequence similarities”, FEBS Lett., Vol. 343, (1994), pp. 109–114.PubMedCrossRefGoogle Scholar
  12. [12]
    A.M. Dulhanty and J.R. Riordan: “Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator”, Biochemistry Vol. 33, (1994), pp. 4072–4079.PubMedCrossRefGoogle Scholar
  13. [13]
    L.S. Ostedgaard et al.: “A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution”, Proc. Natl. Acad. Sci. USA Vol. 97, (2000), pp. 5657–5662.PubMedCrossRefGoogle Scholar
  14. [14]
    J.E. Stajich et al.: “The Bioperl toolkit: Perl modules for the life sciences”, Genome. Res., Vol. 12, (2002), pp. 1611–1618.PubMedCrossRefGoogle Scholar
  15. [15]
    A. Bairoch et al.: “The Universal Protein Resource (UniProt)”, Nucleic Acids Res., Vol. 33, (2005), pp. D154–D159.PubMedCrossRefGoogle Scholar
  16. [16]
    C. del Val et al.: “High-throughput protein analysis integrating bioinformatics and experimental assays”, Nucleic Acids Res. Vol. 32, (2004), pp. 742–748.PubMedCrossRefGoogle Scholar
  17. [17]
    E.L. Grogan et al.: “Volatility: a new vital sign identified using a novel bedside monitoring strategy”, J. Trauma., Vol. 58, (2005), pp. 7–12; discussion 12-14.PubMedCrossRefGoogle Scholar
  18. [18]
    L.S. Ostedgaard, O. Baldursson and M.J. Welsh: “Regulation of the cystic fibrosis transmembrane conductance regulator Cl-channel by its R domain”, J. Biol. Chem., Vol. 276, (2001), pp. 7689–7692.PubMedCrossRefGoogle Scholar
  19. [19]
    V. Chappe et al.: “Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator”, Proc. Natl. Acad. Sci. USA, Vol. 101, (2004), pp. 390–395.PubMedCrossRefGoogle Scholar
  20. [20]
    L. Csanady et al.: “Functional roles of nonconserved structural segments in CFTR’s NH2-terminal nucleotide binding domain”, J. Gen. Physiol., Vol. 125, (2005), pp. 43–55.PubMedCrossRefGoogle Scholar
  21. [21]
    L. Wei et al.: “The C-terminal part of the R-domain, but not the PDZ binding motif, of CFTR is involved in interaction with Ca(2+)-activated Cl-channels”, Pflugers Arch. Vol. 442, (2001), pp. 280–285.PubMedCrossRefGoogle Scholar
  22. [22]
    S.B. Ko et al.: “Gating of CFTR by the STAS domain of SLC26 transporters”, Nat. Cell. Biol. Vol. 6, (2004), pp. 343–350.PubMedCrossRefGoogle Scholar
  23. [23]
    D.B. Mount and M.F. Romero: “The SLC26 gene family of multifunctional anion exchangers”, Pflugers Arch., Vol. 447, (2004), pp. 710–721.PubMedCrossRefGoogle Scholar
  24. [24]
    M.J. Hug, T. Tamada and R.J. Bridges: “CFTR and bicarbonate secretion by [correction of to] epithelial cells”, News Physiol. Sci. Vol. 18, (2003), pp. 38–42.PubMedGoogle Scholar
  25. [25]
    A. Hemminki et al.: “Intestinal cancer in patients with a germline mutation in the down-regulated in adenoma (DRA) gene”, Oncogene, Vol. 16, (1998), pp. 681–684.PubMedCrossRefGoogle Scholar
  26. [26]
    J.M. Chapman et al.: “The colon anion transporter, down-regulated in adenoma, induces growth suppression that is abrogated by E1A”, Cancer Res. Vol. 62, (2002), pp. 5083–5088.PubMedGoogle Scholar
  27. [27]
    E.M. Schwiebert et al.: “CFTR is a conductance regulator as well as a chloride channel”, Physiol. Rev. Vol. 79, (1999), pp. S145–S166.PubMedGoogle Scholar
  28. [28]
    K. Kunzelmann: “CFTR: interacting with everything?”, News Physiol. Sci. Vol. 16, (2001), pp. 167–170.PubMedGoogle Scholar
  29. [29]
    A.P. Naren et al.: “A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA”, Proc. Natl. Acad. Sci. USA, Vol. 100, (2003), pp. 342–346.PubMedCrossRefGoogle Scholar
  30. [30]
    A.R. Cantrell et al.: “Molecular mechanism of convergent regulation of brain Na(+) channels by protein kinase C and protein kinase A anchored to AKAP-15”, Mol. Cell. Neurosci. Vol. 21, (2002), pp. 63–80.PubMedCrossRefGoogle Scholar
  31. [31]
    W.B. Thornhill and S.R. Levinson: “Biosynthesis of ion channels in cell-free and metabolically labeled cell systems”, Methods Enzymol Vol. 207, (1992), pp. 659–670.PubMedCrossRefGoogle Scholar
  32. [32]
    S. Pind„ J.R. Riordan and D.B. Williams: “Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator”, J. Biol. Chem., Vol. 269, (1994), pp. 12784–12788.PubMedGoogle Scholar
  33. [33]
    S.P. Shah et al.: “Atlas — a data warehouse for integrative bioinformatics”, BMC Bioinformatics, Vol. 6, (2005), pp. 34.PubMedCrossRefGoogle Scholar
  34. [34]
    G. Xie et al.: “Storing biological sequence databases in relational form”, Bioinformatics, Vol. 16, (2000), pp. 288–289.PubMedCrossRefGoogle Scholar
  35. [35]
    J. Kohler, S. Philippi and M. Lange: “SEMEDA: ontology based semantic integration of biological databases”, Bioinformatics, Vol. 19, (2003), pp. 2420–2427.PubMedCrossRefGoogle Scholar
  36. [36]
    S. Philippi: “Light-weight integration of molecular biological databases”, Bioinformatics, Vol. 20, (2004), pp. 51–57.PubMedCrossRefGoogle Scholar
  37. [37]
    S. Stephens: “Data Integration and Knowledge Aggregation in Life Sciences Discovery”, Scientific Comput. Instrum. Vol. 21, (2005).Google Scholar
  38. [38]
    G. Finak et al.: “BIAS: Bioinformatics Integrated Application Software”, Bioinformatics, Vol. 21, (2005), pp. 1745–1746.PubMedCrossRefGoogle Scholar
  39. [39]
    S.A. Kirov et al.: “GeneKeyDB: a lightweight, gene-centric, relational database to support data mining environments”, BMC Bioinformatics, Vol. 6, (2005), pp. 72.PubMedCrossRefGoogle Scholar
  40. [40]
    S.P. Shah et al.: “Pegasys: software for executing and integrating analyses of biological sequences”, BMC Bioinformatics Vol. 5, (2004), pp. 40.PubMedCrossRefGoogle Scholar

Copyright information

© Central European Science Journals Warsaw and Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  1. 1.Department of Biochemistry & Biophysics and Cystic Fibrosis T&R CenterUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations